The IOGP-Ipieca joint Health Committee has followed the development, rollout, and real-world efficacy of COVID-19 vaccines since they became available in late 2020. In late 2021, we are confident that vaccines provide one of the most effective tools to mitigate the spread and consequences of COVID-19.
Joint IOGP-Ipieca position on COVID-19 vaccines

1 July 2021
Share this resource
Related resources
- 1 July 2021
This is the fifth version of this document and presents the Committee's views on testing, isolation, and quarantine in industry workplaces.
View
- 1 July 2021
This document provides a list of factors for oil and gas industry companies to consider as they prepare for their workers to return to offices.
View
- 1 May 2020
This position paper explores how the pandemic is impacting mental health, mental health threat factors, their business-related impacts and prevention and mitigation measures.
View
- 19 February 2025
This joint Ipieca-IOGP awareness briefing explores what is currently known about the health risks associated with energy transition-focused technologies.
View